Ly Tran

466 total citations
21 papers, 333 citations indexed

About

Ly Tran is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Ly Tran has authored 21 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Pathology and Forensic Medicine and 5 papers in Rheumatology. Recurrent topics in Ly Tran's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ly Tran is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ly Tran collaborates with scholars based in Netherlands, United States and Vietnam. Ly Tran's co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Joke W. Baars, Albert J.H. Suurmeijer, Elisabeth G.E. de Vries, Pieter L. Jager, Steven de Jong, Joost Bart, Jos G. W. Kosterink and Marjolijn N. Lub‐de Hooge and has published in prestigious journals such as British Journal of Pharmacology, Annals of the Rheumatic Diseases and International Journal of Environmental Research and Public Health.

In The Last Decade

Ly Tran

17 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ly Tran Netherlands 8 181 111 99 70 47 21 333
Philip Hamann United Kingdom 9 194 1.1× 93 0.8× 76 0.8× 60 0.9× 91 1.9× 17 416
Noah Richardson United States 5 57 0.3× 193 1.7× 51 0.5× 150 2.1× 64 1.4× 13 331
Nancy S. Scher United States 6 129 0.7× 276 2.5× 23 0.2× 26 0.4× 95 2.0× 8 419
Julia K. L. Woodward United Kingdom 12 78 0.4× 233 2.1× 19 0.2× 46 0.7× 191 4.1× 14 415
Andrea Viqueira Spain 10 67 0.4× 151 1.4× 77 0.8× 28 0.4× 72 1.5× 59 355
Ulrich Krafft Germany 12 70 0.4× 113 1.0× 28 0.3× 23 0.3× 79 1.7× 39 406
Kathrin Philipp‐Abbrederis Germany 4 107 0.6× 188 1.7× 7 0.1× 83 1.2× 43 0.9× 5 284
Spyridon Sideris Belgium 11 189 1.0× 158 1.4× 25 0.3× 19 0.3× 65 1.4× 27 504
Birthe Heitkötter Germany 9 87 0.5× 103 0.9× 20 0.2× 46 0.7× 50 1.1× 18 323
Elías Gracia Cuba 7 60 0.3× 156 1.4× 11 0.1× 41 0.6× 64 1.4× 13 289

Countries citing papers authored by Ly Tran

Since Specialization
Citations

This map shows the geographic impact of Ly Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ly Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ly Tran more than expected).

Fields of papers citing papers by Ly Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ly Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ly Tran. The network helps show where Ly Tran may publish in the future.

Co-authorship network of co-authors of Ly Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Ly Tran. A scholar is included among the top collaborators of Ly Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ly Tran. Ly Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Ly, Miles Smith, Fenping Zheng, et al.. (2021). Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus*. British Journal of Dermatology. 185(3). 563–572. 11 indexed citations
2.
Slight‐Webb, Samantha, Carla Guthridge, Hua Chen, et al.. (2021). Unique Serum Immune Phenotypes and Stratification of Oklahoma Native American Rheumatic Disease Patients. Arthritis Care & Research. 75(4). 936–946. 3 indexed citations
3.
Merrill, Joan T., Joel M. Guthridge, Donald J. Zack, et al.. (2020). SAT0187 DISCRIMINATION OF SYSTEMIC LUPUS (SLE) PATIENTS WITH CLINICAL RESPONSE TO OBEXELIMAB (XMAB®5871) BASED ON A PATTERN OF IMMUNOLOGIC MARKERS. Annals of the Rheumatic Diseases. 79. 1035–1036. 4 indexed citations
4.
Guthridge, Joel M., Rufei Lu, Ly Tran, et al.. (2020). Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study. EClinicalMedicine. 20. 100291–100291. 55 indexed citations
5.
Bui, Thanh Cong, et al.. (2020). Factors Associated with Cigarette Smoking Cessation in Lao People’s Democratic Republic: Results from the 2015 National Adult Tobacco Survey. International Journal of Environmental Research and Public Health. 17(14). 4953–4953.
6.
Siengsounthone, Latsamy, et al.. (2019). Tobacco use in Lao People’s Democratic Republic: Resultsfrom the 2015 National Adult Tobacco Survey. Tobacco Prevention & Cessation. 5(September). 31–31. 3 indexed citations
7.
Tran, Ly, et al.. (2019). 1410. Serious Cryptococcal Infections with Ruxolitinib Use: A Case of Meningitis and a Review of the Literature. Open Forum Infectious Diseases. 6(Supplement_2). S513–S514. 2 indexed citations
8.
Tran, Ly, Mathew Thomas, Jeremy N. Harvey, Rahul Sampath, & Richard C. Rose. (2019). 1700. A Rare Case of Candida glabrata Hemorrhagic Cystitis with Empagliflozin Use. Open Forum Infectious Diseases. 6(Supplement_2). S622–S623.
9.
Tran, Ly, et al.. (2019). Recurrence rate and associated factors of borderline ovarian tumors in the south of Vietnam. Journal of obstetrics and gynaecology research. 45(10). 2055–2061. 9 indexed citations
10.
Thomas, Mathew, et al.. (2019). SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis. Journal of the Endocrine Society. 3(Supplement_1).
11.
Tran, Ly, Joke W. Baars, Carola W.N. Damen, Jos H. Beijnen, & Alwin D. R. Huitema. (2011). Three spectroscopic techniques evaluated as a tool to study the effects of iodination of monoclonal antibodies, exemplified by rituximab. Journal of Pharmaceutical and Biomedical Analysis. 56(3). 609–614. 4 indexed citations
12.
Tran, Ly, Alwin D. R. Huitema, M. H. van Rijswijk, et al.. (2011). CD20 antigen imaging with 124I-rituximab PET/CT in patients with rheumatoid arthritis. Human Antibodies. 20(1-2). 29–35. 28 indexed citations
13.
14.
Tran, Ly, Wouter V. Vogel, M. Sinaasappel, et al.. (2011). The pharmacokinetics of 124I-rituximab in patients with rheumatoid arthritis. Human Antibodies. 20(1-2). 7–14. 5 indexed citations
15.
Tran, Ly, Alwin D. R. Huitema, M. H. van Rijswijk, et al.. (2011). CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.. PubMed. 20(1-2). 29–35. 31 indexed citations
16.
Tran, Ly, Johanna W. Baars, Jan Paul de Boer, et al.. (2011). The pharmacokinetics of 131I-rituximab in a patient with CD20 positive Non-Hodgkin Lymphoma: Evaluation of the effect of radioiodination on the biological properties of rituximab. Human Antibodies. 20(1-2). 37–40. 2 indexed citations
17.
Tran, Ly, Joke W. Baars, L Aarden, Jos H. Beijnen, & Alwin D. R. Huitema. (2010). Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies. Human Antibodies. 19(1). 7–13. 21 indexed citations
18.
Tran, Ly, et al.. (2009). A Simple and Safe Method for 131 I Radiolabeling of Rituximab for Myeloablative High-Dose Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 24(1). 103–110. 14 indexed citations
19.
Tran, Ly, Jos H. Beijnen, & Alwin D. R. Huitema. (2009). The preparation of radiolabeled monoclonal antibodies for human use. Human Antibodies. 18(4). 145–156. 2 indexed citations
20.
Hooge, Marjolijn N. Lub‐de, Jos G. W. Kosterink, Patrick J. Perik, et al.. (2004). Preclinical characterisation of 111In‐DTPA‐trastuzumab. British Journal of Pharmacology. 143(1). 99–106. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Hamann Breakdown of academic impact, for papers by Noah Richardson Breakdown of academic impact, for papers by Nancy S. Scher Breakdown of academic impact, for papers by Julia K. L. Woodward Breakdown of academic impact, for papers by Andrea Viqueira Breakdown of academic impact, for papers by Ulrich Krafft Breakdown of academic impact, for papers by Kathrin Philipp‐Abbrederis Breakdown of academic impact, for papers by Spyridon Sideris Breakdown of academic impact, for papers by Birthe Heitkötter Breakdown of academic impact, for papers by Elías Gracia
Rankless by CCL
2026